These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26175637)

  • 1. Perioperative management of antithrombotic and antiplatelet therapy.
    Bracey AW
    Tex Heart Inst J; 2015 Jun; 42(3):239-42. PubMed ID: 26175637
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel antiplatelet and anticoagulant agents in the cardiac care unit.
    Garg VP; Halperin JL
    Cardiol Clin; 2013 Nov; 31(4):533-44, viii. PubMed ID: 24188219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bridging: Perioperative management of chronic anticoagulation or antiplatelet therapy].
    Nowak-Göttl U; Langer F; Limperger V; Mesters R; Trappe RU
    Dtsch Med Wochenschr; 2014 Jun; 139(24):1301-6. PubMed ID: 24892468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of traditional and novel oral anticoagulant and antiplatelet therapy for dermatologists and dermatologic surgeons.
    Brown DG; Wilkerson EC; Love WE
    J Am Acad Dermatol; 2015 Mar; 72(3):524-34. PubMed ID: 25486915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative management of warfarin and antiplatelet therapy.
    Jaffer AK
    Cleve Clin J Med; 2009 Nov; 76 Suppl 4():S37-44. PubMed ID: 19880835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of oral anticoagulants in patients with atrial fibrillation.
    Greenspon AJ
    Postgrad Med; 2012 Nov; 124(6):7-16. PubMed ID: 23322134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation.
    Aguilar MI; Kuo RS; Freeman WD
    Neurol Clin; 2013 Aug; 31(3):659-75. PubMed ID: 23896498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
    Lip GY; Larsen TB; Skjøth F; Rasmussen LH
    J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.
    van Nieuwenhuizen KM; van der Worp HB; Algra A; Kappelle LJ; Rinkel GJ; van Gelder IC; Schutgens RE; Klijn CJ;
    Trials; 2015 Sep; 16():393. PubMed ID: 26340977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of new oral anticoagulants with dual antiplatelet therapy in patients with acute coronary syndromes.
    Tsu LV; Dager WE
    Ann Pharmacother; 2013 Apr; 47(4):573-7. PubMed ID: 23548645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative management of patients on chronic antithrombotic therapy.
    Ortel TL
    Blood; 2012 Dec; 120(24):4699-705. PubMed ID: 22855600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint.
    Rubboli A; Agewall S; Huber K; Lip GY
    Int J Cardiol; 2015 Oct; 196():133-8. PubMed ID: 26093527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy.
    Manchikanti L; Falco FJ; Benyamin RM; Caraway DL; Kaye AD; Helm S; Wargo BW; Hansen H; Parr AT; Singh V; Swicegood JR; Smith HS; Schultz DM; Malla Y; Hirsch JA
    Pain Physician; 2013 Apr; 16(2 Suppl):SE261-318. PubMed ID: 23615893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of anticoagulants, antiplatelet agents, and their reversal strategies in the management of intracerebral hemorrhage.
    James RF; Palys V; Lomboy JR; Lamm JR; Simon SD
    Neurosurg Focus; 2013 May; 34(5):E6. PubMed ID: 23634925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New antiplatelet drugs and new oral anticoagulants.
    Koenig-Oberhuber V; Filipovic M
    Br J Anaesth; 2016 Sep; 117 Suppl 2():ii74-ii84. PubMed ID: 27566810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic and anticoagulant therapy for atrial fibrillation.
    Dzeshka MS; Lip GY
    Cardiol Clin; 2014 Nov; 32(4):585-99. PubMed ID: 25443239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of novel and emerging oral anticoagulants for secondary prevention of acute coronary syndromes.
    Ganetsky VS; Hadley DE; Thomas TF
    Pharmacotherapy; 2014 Jun; 34(6):590-604. PubMed ID: 24338703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New oral anticoagulants and perioperative management of anticoagulant/antiplatelet agents.
    Watson A
    Aust Fam Physician; 2015 Mar; 44(3):87. PubMed ID: 25942762
    [No Abstract]   [Full Text] [Related]  

  • 20. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.